• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新辅助放化疗后 T0-1ycN0 期低位直肠癌经肛门局部切除与经括约肌间切除术的对比:基于逆概率加权法的肿瘤学和功能结局分析。

Transanal local excision versus intersphincteric resection for low rectal cancer with stage ypT0-1ycN0 after neoadjuvant chemoradiotherapy: an inverse probability weighting analysis for oncological and functional outcomes.

机构信息

Department of Colorectal Surgery, Fujian Medical University Union Hospital, No.29 Xinquan Road, Fuzhou, 350001, Fujian Province, China.

Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, China.

出版信息

J Cancer Res Clin Oncol. 2023 Dec;149(19):17383-17394. doi: 10.1007/s00432-023-05454-y. Epub 2023 Oct 16.

DOI:10.1007/s00432-023-05454-y
PMID:37843558
Abstract

OBJECTIVES

This study aimed to compare the efficacy of local excision (LE) and intersphincteric resection (ISR) in patients with locally advanced rectal cancer who achieved a significant or complete pathological response following neoadjuvant chemoradiotherapy.

METHODS

We performed a retrospective analysis of data from patients with stage ypT0-1ycN0 low rectal cancer after neoadjuvant chemoradiotherapy who underwent LE or ISR between June 2016 and June 2021. Baseline characteristics, short-term outcomes, long-term oncological outcomes, and functional outcomes, were compared between the two groups. To reduce the selection bias, inverse probability of treatment weighting (IPTW) was performed.

RESULTS

This study included 106 patients (LE group: n = 51, ISR group: n = 55). There were significant differences in baseline characteristics between the two groups (P < 0.05). After IPTW, there were almost no significant differences in baseline data between the two groups. The LE group showed less postoperative complications and better function outcomes compared to the ISR group. The LE group had significantly lower rates of complications (13.7% vs. 36.4%, P = 0.014). There were no significant differences between the two groups in terms of long-term oncological outcomes.

CONCLUSIONS

For patients with locally advanced low rectal cancer achieving significant or complete pathological response after neoadjuvant therapy, both LE and ISR present comparable oncological outcomes. Yet, LE seems to show more advantages in terms of postoperative complications and functional outcomes. These findings offer important insights for surgical decision-making, emphasizing the necessity to consider both oncological and functional outcomes in selecting the optimal surgical approach.

摘要

目的

本研究旨在比较局部切除(LE)和经括约肌间切除术(ISR)在接受新辅助放化疗后获得显著或完全病理缓解的局部晚期直肠癌患者中的疗效。

方法

我们对 2016 年 6 月至 2021 年 6 月接受新辅助放化疗后ypT0-1ycN0 低位直肠癌行 LE 或 ISR 的患者进行了回顾性数据分析。比较两组患者的基线特征、短期结局、长期肿瘤学结局和功能结局。为了减少选择偏倚,进行了逆概率治疗加权(IPTW)。

结果

本研究纳入了 106 例患者(LE 组:n=51,ISR 组:n=55)。两组患者的基线特征存在显著差异(P<0.05)。经 IPTW 后,两组间的基线数据差异几乎无统计学意义。LE 组术后并发症和功能结局优于 ISR 组。LE 组的并发症发生率显著低于 ISR 组(13.7%比 36.4%,P=0.014)。两组患者的长期肿瘤学结局无显著差异。

结论

对于新辅助治疗后获得显著或完全病理缓解的局部晚期低位直肠癌患者,LE 和 ISR 的肿瘤学结局相当。然而,LE 在术后并发症和功能结局方面似乎具有更多优势。这些发现为手术决策提供了重要参考,强调在选择最佳手术方式时,既要考虑肿瘤学结局,也要考虑功能结局。

相似文献

1
Transanal local excision versus intersphincteric resection for low rectal cancer with stage ypT0-1ycN0 after neoadjuvant chemoradiotherapy: an inverse probability weighting analysis for oncological and functional outcomes.新辅助放化疗后 T0-1ycN0 期低位直肠癌经肛门局部切除与经括约肌间切除术的对比:基于逆概率加权法的肿瘤学和功能结局分析。
J Cancer Res Clin Oncol. 2023 Dec;149(19):17383-17394. doi: 10.1007/s00432-023-05454-y. Epub 2023 Oct 16.
2
Oncological Outcomes of Intersphincteric Resection Versus Abdominoperineal Resection for ypT3 Low Rectal Cancer After Neoadjuvant Chemoradiotherapy: A Multicenter Retrospective Analysis.新辅助放化疗后ypT3期低位直肠癌行括约肌间切除术与腹会阴联合切除术的肿瘤学结局:一项多中心回顾性分析
Dis Colon Rectum. 2025 Aug 1;68(8):951-961. doi: 10.1097/DCR.0000000000003821. Epub 2025 May 7.
3
Short-term outcomes of transanal endoscopic intersphincteric resection for locally advanced rectal cancer after neoadjuvant chemoradiotherapy: A single-center retrospective cohort study.新辅助放化疗后经肛门内镜括约肌间切除术治疗局部晚期直肠癌的短期疗效:一项单中心回顾性队列研究
Eur J Surg Oncol. 2025 Jul;51(7):109984. doi: 10.1016/j.ejso.2025.109984. Epub 2025 Mar 21.
4
Completion total mesorectal excision after neoadjuvant radiochemotherapy and local excision for rectal cancer.直肠癌新辅助放化疗后完成全直肠系膜切除术和局部切除术。
Colorectal Dis. 2024 Feb;26(2):281-289. doi: 10.1111/codi.16834. Epub 2023 Dec 22.
5
Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.对局部晚期宫颈癌女性患者进行子宫切除术并辅以放疗或化疗或两者联合治疗。
Cochrane Database Syst Rev. 2015 Apr 7(4):CD010260. doi: 10.1002/14651858.CD010260.pub2.
6
Oncologic outcomes of watch-and-wait strategy or surgery for low to intermediate rectal cancer in clinical complete remission after adjuvant chemotherapy: a systematic review and meta-analysis.辅助化疗后临床完全缓解的低至中危直肠肿瘤行观察等待策略或手术的肿瘤学结局:系统评价和荟萃分析。
Int J Colorectal Dis. 2023 Oct 3;38(1):246. doi: 10.1007/s00384-023-04534-2.
7
Oncological outcomes of local excision compared with radical surgery after neoadjuvant chemoradiotherapy for rectal cancer: a systematic review and meta-analysis.新辅助放化疗后直肠癌局部切除与根治性手术的肿瘤学结局:一项系统评价和荟萃分析
Int J Colorectal Dis. 2015 Jan;30(1):19-29. doi: 10.1007/s00384-014-2045-1. Epub 2014 Nov 4.
8
Evaluating the Impact of Induction and Consolidation Total Neoadjuvant Therapies Compared to Conventional Chemoradiotherapy for Locally Advanced Rectal Cancer: A Systematic Review and Network Meta-analysis.评估诱导和巩固性全新辅助治疗与传统放化疗相比对局部晚期直肠癌的影响:一项系统评价和网状Meta分析
Dis Colon Rectum. 2025 Jun 1;68(6):687-701. doi: 10.1097/DCR.0000000000003687. Epub 2025 Mar 10.
9
Surgical, oncological, and functional outcomes of local and radical resection after neoadjuvant chemotherapy or chemoradiotherapy for early- and mid-stage rectal cancer: a systematic review and meta-analysis.新辅助化疗或放化疗后局部和根治性切除治疗早期和中期直肠癌的手术、肿瘤学和功能结局:系统评价和荟萃分析。
Int J Colorectal Dis. 2023 May 16;38(1):132. doi: 10.1007/s00384-023-04433-6.
10
Tailored selection of the interval between neoadjuvant chemoradiotherapy and surgery for locally advanced rectal cancer: analysis based on the pathologic stage or chemoradiation response.局部晚期直肠癌新辅助放化疗与手术间隔时间的个体化选择:基于病理分期或放化疗反应的分析
J Cancer Res Clin Oncol. 2015 Apr;141(4):719-28. doi: 10.1007/s00432-014-1843-8. Epub 2014 Oct 9.

引用本文的文献

1
Therapeutic strategies for ypT1 rectal cancer after neoadjuvant chemoradiotherapy: a retrospective cohort study.新辅助放化疗后 ypT1 直肠癌的治疗策略:一项回顾性队列研究。
Int J Colorectal Dis. 2024 Nov 26;39(1):189. doi: 10.1007/s00384-024-04764-y.
2
Predicting unplanned readmission due to cardiovascular disease in hospitalized patients with cancer: a machine learning approach.预测因癌症住院患者因心血管疾病而再次入院:一种机器学习方法。
Sci Rep. 2023 Aug 18;13(1):13491. doi: 10.1038/s41598-023-40552-4.

本文引用的文献

1
International standardization and optimization group for intersphincteric resection (ISOG-ISR): modified Delphi consensus on anatomy, definition, indication, surgical technique, specimen description and functional outcome.国际肛门直肠外科医师协会(ISRA)间置括约肌切除术(ISR)国际标准化与优化工作组:关于解剖、定义、适应证、手术技术、标本描述和功能结果的改良 Delphi 共识。
Colorectal Dis. 2023 Sep;25(9):1896-1909. doi: 10.1111/codi.16704. Epub 2023 Aug 10.
2
The Risk of Distant Metastases in Patients With Clinical Complete Response Managed by Watch and Wait After Neoadjuvant Therapy for Rectal Cancer: The Influence of Local Regrowth in the International Watch and Wait Database.新辅助治疗后采用观察等待策略管理的临床完全缓解直肠癌患者远处转移的风险:国际观察等待数据库中局部复发的影响
Dis Colon Rectum. 2023 Jan 1;66(1):41-49. doi: 10.1097/DCR.0000000000002494. Epub 2022 Oct 21.
3
Chemoradiation and consolidation chemotherapy for rectal cancer provides a high rate of organ preservation with a very good long-term oncological outcome: a single-center cohort series.直肠癌的放化疗和巩固化疗可提供高的器官保存率和非常好的长期肿瘤学结果:一项单中心队列研究。
World J Surg Oncol. 2022 Nov 10;20(1):358. doi: 10.1186/s12957-022-02816-7.
4
Targeted Radiotherapy Using Contact X-ray Brachytherapy 50 kV.使用50 kV接触式X射线近距离放射疗法的靶向放射治疗
Cancers (Basel). 2022 Mar 3;14(5):1313. doi: 10.3390/cancers14051313.
5
Transanal Endoscopic Microsurgery Versus Total Mesorectal Excision in ypT0-1 Rectal Cancer After Preoperative Radiochemotherapy: Postoperative Morbidity, Functional Results, and Long-term Oncologic Outcome.经术前放化疗后 ypT0-1 期直肠腺癌患者行经肛门内镜微创手术与全直肠系膜切除术的对比:术后并发症、功能结果和长期肿瘤学转归。
Dis Colon Rectum. 2022 Nov 1;65(11):1306-1315. doi: 10.1097/DCR.0000000000002255. Epub 2022 Jan 20.
6
International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer.国际共识推荐意见:直肠癌患者接受(放)化疗后器官保存的关键结局指标
Nat Rev Clin Oncol. 2021 Dec;18(12):805-816. doi: 10.1038/s41571-021-00538-5. Epub 2021 Aug 4.
7
Intersphincteric resection for low rectal cancer: the risk is functional rather than oncological. A 25-year experience from Bordeaux.经肛门内外括约肌间切除术治疗低位直肠癌:风险是功能性的而不是肿瘤学上的。来自波尔多的 25 年经验。
Colorectal Dis. 2020 Nov;22(11):1603-1613. doi: 10.1111/codi.15258. Epub 2020 Sep 5.
8
[Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].巩固性新辅助治疗或全新辅助治疗后低位直肠癌的保直肠手术:初步报告
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Mar 25;23(3):281-288. doi: 10.3760/cma.j.cn.441530-20200228-00096.
9
Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial.直肠癌的放化疗联合局部切除保肛治疗:GRECCAR 2 随机试验的 5 年结果。
Lancet Gastroenterol Hepatol. 2020 May;5(5):465-474. doi: 10.1016/S2468-1253(19)30410-8. Epub 2020 Feb 7.
10
Predictive Factors for Bowel Dysfunction After Sphincter-Preserving Surgery for Rectal Cancer: A Single-Center Cross-sectional Study.保肛手术治疗直肠癌后肠功能障碍的预测因素:单中心横断面研究。
Dis Colon Rectum. 2019 Aug;62(8):925-933. doi: 10.1097/DCR.0000000000001374.